Intermolecular, Inc. announced that Epistar Corp. and Intermolecular have signed a multi-year extension of their existing collaborative development program (CDP) and royalty-bearing IP licensing agreement to increase the efficiency and reduce the cost of Epistar's light emitting diode (LED) devices.

Intermolecular announced on the 17th that it has signed a collaborative development program (CDP) and royalty-bearing IP licensing agreement with Taiwan Epistar, in order to jointly improve power of LED devices and reduce production costs of the latter. The engineers from Epistar and Intermolecular will take the advantages of Intermolecular's highly productive combination (HPC) technology platform based on this agreement to vigorously promote the development and manufacturing of advanced new materials and processing technology for LED products. "After a r...